Relating drug–protein interaction network with drug side effects
Author(s) -
Sayaka Mizutani,
Edouard Pauwels,
Véronique Stoven,
Susumu Goto,
Yoshihiro Yamanishi
Publication year - 2012
Publication title -
bioinformatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.599
H-Index - 390
eISSN - 1367-4811
pISSN - 1367-4803
DOI - 10.1093/bioinformatics/bts383
Subject(s) - drug , kegg , computational biology , side effect (computer science) , drug discovery , gene ontology , drug development , biology , bioinformatics , gene , pharmacology , computer science , genetics , gene expression , programming language
Identifying the emergence and underlying mechanisms of drug side effects is a challenging task in the drug development process. This underscores the importance of system-wide approaches for linking different scales of drug actions; namely drug-protein interactions (molecular scale) and side effects (phenotypic scale) toward side effect prediction for uncharacterized drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom